Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome


EYÜPOĞLU N. D. , ERGÜNAY K. , AÇIKGÖZ PINAR A. , AKYÖN YILMAZ Y. , Yilmaz E. , Yildiz B. O.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol.105, no.12, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 105 Issue: 12
  • Publication Date: 2020
  • Doi Number: 10.1210/clinem/dgaa600
  • Title of Journal : JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Abstract

Context: Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder. Emerging animal and human data point to various changes in microbiota that could be linked with the syndrome. However, the effects of therapeutic approaches on gut microbial composition in women with PCOS remain unknown.